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Abstract
Background: The predicting of pituitary tumor behavior remains one of the most incurable medical problems. One of the causes is poor correlation 
between the morphology of pituitary tumors and their clinical aggressiveness.  
Material and methods: 96 cases included in our study have been microscopically investigated on specimens colored with eosin haematoxylin by three 
experienced pathologists according to WHO recommendations. Out of these ten cases were represented by normal pituitary tissue to make it possible 
to compare the typical pituitary morphology with the microscopic appearance of various types of pituitary adenomas.
results: In both the normal pituitary gland and in pituitary adenomas, endothelial cells presenting a nuclear expression for S100 were occasionally 
observed.  The percentage of positive cases for protein S100 was 66.12% from the total number of cases. Amongst these, 39.02% presented a compact growth 
pattern, 39.04% were of papillary type, 9.75% presented a trabecular growth pattern, 4.87% spindle-shaped and 7.31% were of alveolar type. Papillary 
type pituitary adenomas registered the highest intensity of expression for protein S100 in tumor cells. The acidophilic cells were present in a percentage 
of 34.2% of cases. Pituitary adenomas with basophilic cells represented a percentage of 26.8% of positive cases for protein S100, and, for 39% of cases the 
chromofobe component was present forming pure chromofobe pituitary adenomas or mixed chromofobe-acidophilic/basophilic pituitary adenomas.
conclusions: Protein S100 expressions in tumor cells is implicated in the pathogenesis of the growth hormone and prolactin secreting pituitary adenomas, 
the mechanisms of activation being nowadays incompletely studied.  Through analogy with the observations obtained in other tumor types, it is possible 
that S100 pituitary adenomas to represent a group of pituitary adenomas with an aggressive behavior and a high capacity of invasion and recurrence, 
aspects that represent an unfavorable prognostic factor.
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Introduction
Predicting of pituitary tumor behavior remains one of the 
most incurable medical problems. One of the causes is poor 
correlation between the morphology of pituitary tumors and 
their clinical aggressiveness.  Pituitary tumors have been 
strongly scrutinized for their immunohistochemical expressi-
on of a wide range of proteins, growth factor, cytokines and 
various gene products in hope to find prognostic markers. 
The aims of the present work were to study the presence and 
distribution of S100 protein-immunoreactive cells to assess 
their response in cases of various types of pituitary adenomas. 
Protein S100 was originally isolated in the central nervous 
system and has been localized in folliculo-stellate sells of the 
anterior lobe of the pituitary gland.
Material and methods
The research was carried out at the Department of Mor-
phopathology of Nicolae Testemitsanu State University of 
Medicine and Pharmacy in 2012-2015 period. The research 
protocol has got the Research Ethics Committee approval 
(protocol No 52 of 08.06.2015)
96 cases included in our study have been microscopically 
investigated on specimens colored with eosin haematoxylin 
by three experienced pathologists according to WHO re-
commendations. Out of these ten cases were represented by 
normal pituitary tissue to make it possible to compare the 
typical pituitary morphology with the microscopic appearance 
of various types of pituitary adenomas.
The studied samples were taken from the postoperative 
pieces (surgically removed pituitary adenomas), which were 
set in a 4% formalin solution buffered at pH 7.2 for 48-72 
hours and placed into paraffin, using the common histologi-
cal technique Thermo Shandon standardized and automated 
system (Thermo Fisher Scientific Inc., Waltham, MA, USA). 
The microscopy was performed using Nikon Eclipse E600 mi-
croscope (Nikon Corporation, Tokyo, Japan), the images being 
taken with Coolpix 950 digital camera in JPEG format. The 
data are presented as absolute and relative expressions (%).
Results
Protein S100 in pituitary adenomas was also studied by 
using the immunohistochemical method on the normal pi-
tuitary gland and in pituitary adenomas. Protein S100 proved 
to have a nuclear and cytoplasmic pattern, being positive in 
the stellate follicular cells but also in the endocrine cells of 
the normal pituitary gland (fig. 1) and the adenomatous ones. 
Fig. 1.  The expression of protein S100 in the normal pituitary 
gland. note the intense, nuclear and cytoplasmic expression in 
the stelate follicular cells and the moderate cytoplasm-restricted 
expression in the endocrine cells with an acidophilic pattern on 
hematoxilin-eosine and a low intensity in chromofobe cells.
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The combined nuclear/cytoplasmic pattern was observed 
in tumor cells in only 19.5% of S100 positive cases (fig. 2 a), 
the rest of the cases presenting a cytoplasm-restricted expre-
ssion (fig. 2 b). 
In both the normal pituitary gland and in pituitary ade-
nomas, endothelial cells presenting a nuclear expression for 
S100 were occasionally observed (fig. 3 a, b).
The percentage of positive cases for protein S100 was 
66.12% from the total number of cases. Amongst these, 
39.02% presented a compact growth pattern, 39.04% were of 
papillary type, 9.75% presented a trabecular growth pattern, 
4.87% spindle-shaped and 7.31% were of alveolar type. Papil-
lary type pituitary adenomas registered the highest intensity 
of expression for protein S100 in tumor cells (fig. 4a). With 
the exception of papillary type adenomas, in the majority of 
pituitary adenoma cases the intensity of the reaction was low 
and moderate, in comparison with the normal tissue (fig. 4b).
The acidophilic cells were present in percentage of 34.2% 
of cases. Pituitary adenomas with basophilic cells represented 
percentage of 26.8% of positive cases for protein S100, and, in 
39% of cases the chromofobe component was present forming 
pure chromofobe pituitary adenomas or mixed chromofobe-
acidophilic/basophilic pituitary adenomas. 
Regarding the particularities of the immunohistochemical 
expression of protein S100, we observed variabilities in the 
presence, intensity and distribution of this marker in relation 
to the hormone profile. Growth hormone secreting pituitary 
adenomas proved to be extremely hetherogenous in what is 
considered the expression of protein S100 in tumor cells. The 
cases ranged from the absence of its expression in tumor cells 
(stellate follicular cells being positive, fig. 5 a) to a low expre-
ssion, strictly located in the cytoplasm (fig. 5 b), an intense 
expression, in the entire tumor area, nuclear and cytoplasmic 
(c) or just cytoplasmic (d). 
In case of pituitary adenomas with chromofobe cells, the 
expression of protein S100 was low in the cytoplasm of the 
chromofobe cells, being mostly nuclear restricted (fig. 6). 
Tumor cells were negative for protein S100. On the other 
Fig. 2 a.  S100 tumor cells, with a combined nuclear and cytoplasmic pattern.
Fig. 2 b.  S100 tumor cells, exhibiting a cytoplasmic pattern.
Fig. 3.  The positive immunohistochemical reaction for protein S100 with a nuclear expression in the endothelial cells that line the blood 
capillaries from the normal pituitary gland (a, arrow) and from the vessels belonging to pituitary adenomas (b, arrow). 
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hand, around the vascular spaces, S100 positive cells were 
distributed, having a nuclear and cytoplasmic expression, 
and morphology similar to that of stellate follicular cells. The 
expansions of the stellate follicular cells were strongly attached 
to the wall of the blood vessel, being also interconnected 
with one another (fig. 7a). These interconnections created a 
network of S100 positive expansions amongst which tumor 
Fig. 4.  The high intensity of protein S100 in the papillary type pituitary adenomas (a) and the moderate expression  
in the adenomatos tissue (b, right section) compared to the normal pituitary gland (b, left section).
Fig. 5.  The variability of protein S100 expression in growth hormone secreting pituitary adenomas:  
absent (a), low (b), intense, nuclear and cytoplasmic (c), intense, cytoplasmic (d).
cells were distributed. Focally, in the immediate vicinity of the 
S100 positive cells, tumor cells presented a low and inconstant 
reaction with a strict cytoplasmic distribution (fig. 7b). 
As in the case of growth hormone secreting pituitary 
adenomas, the endothelial cells of the vessels located in the 
vicinity of the S100 positive cells had a positive reaction for 
protein S-100 with a nuclear distribution (fig. 7c). In the rest of 
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Fig. 6.  chromofobe type pituitary adenoma with chromofobe 
cells negative for protein S100 in their cytoplasm, with a focal 
and hetherogenous expression in the nuclei of the chromofobe 
cells and in the cytoplasm and the nucleus of stellate follicular 
cells inserted amongst chromofobe cells. In this case also,  
we may note the presence of endothelial cells that have  
a nuclear positive reaction for protein S100.
Fig. 7.  Protein S100 is expressed in AcTH secreting pituitary adenomas. S100 positive cells, at a nuclear and cytoplasmic level, 
distributed in palisade around the blood vessels (a). These cells present numerous branched expansions, inserted amongst tumor cells, 
on the one hand and interconnected with one another forming networks (b, c). On occasion, S100 positive cells were observed as groups 
located amongst tumor cells that presented a low focal reaction for protein S100 (b, d).
the tumor mass the S100 positive cells with a stellate follicular 
morphology were rarely encountered in adrenocorticotropic 
hormone (ACTH) secreting pituitary adenomas. 
In relation to the hormone profile, none of the six mar-
kers used for immunohistochemical profiling significantly 
correlated from a statistical point of view with the expression 
of protein S100.
Discussion
Protein S100 expression was studied in pituitary adeno-
mas, being frequently associated with stellate follicular cells 
[1, 2]. Their expression in tumor cells, separately quantified 
in various types of pituitary adenomas represents a sporadic 
subject in literature and, due to this reason; the correlations 
with the prognosis, long term survival, recurrences and thera-
peutic implications are extremely unconvincing at the time 
being. Increasing data suggest the capacity of tumor endocrine 
and non-endocrine cells to transdifferentiate themselves in 
stellate follicular cells where the two markers overlap in what 
is considered their immunohistochemical expression, these 
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FS cells actually being considered as pluripotent stem cells 
[3, 4]. The “retrodifferentiation” phenomenon was observed 
and described especially in case of ACTH secreting pituitary 
adenomas [4]. In our study we also observed a particular as-
pect of distribution, localization and S100 expression in case 
of ACTH secreting pituitary adenomas.
As a paradox, the description of protein S100 expression 
in the normal pituitary gland is restricted only at the evalua-
tion of foliculostimulating hormone cells. We have not found 
any data in the literature regarding protein S100 expression, 
differentiated in the endocrine cells of the normal human 
pituitary gland. We observed a moderate immunohistochemi-
cal expression in the acidophilic, growth hormone secreting 
cells, and low in the chromofobe cells. The expression pattern 
also remained in case of growth hormone secreting pituitary 
adenomas where we noticed a variability of S100 expressions. 
This aspect was visible especially in case of mixed pituitary 
adenomas where the growth hormone secreting component 
was intensely positive for protein S100 while the basophilic 
component was negative or the chromofobe one was low 
positive for protein S100. 
Conclusions
1. Protein S100 expressions in tumor cells is implicated in
the pathogenesis of the growth hormone and prolactin secreting 
pituitary adenomas, the mechanisms of activation being nowa-
days incompletely studied. This aspect seems to represent an un-
favorable prognostic factor that governs the retrodifferentiation 
phenomenon and supports the presence of pluripotent stem cells.
2. Through analogy with the observations obtained in
other tumor types, it is possible that protein S100 pituitary 
adenomas to represent a group of pituitary adenomas with an 
aggressive behavior and a high capacity of invasion and recur-
rence, aspects that represent an unfavorable prognostic factor.
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